The Hyponatremia Hypothesis: A Cellular Sodium Struggle at the Origin of Autism Spectrum Disorder

Many established and suspected contributors to autism—pharmacologic AVP/OXT analogues, stressors that raise vasopressin, and exposures that increase free water or non-ionic osmoles—push the fetus/infant toward hypo-osmolality and hyponatremic pressure. While frank hyponatremia likely occurs in a subset, we propose that in many cases the developmental morbidity (progression toward autism-spectrum phenotypes) arises from the body’s countermeasures to avoid hyponatremia. These compensations produce a discordant AVP–RAAS–cortisol triad, with intermittent RAAS spikes and cortisol-dominant pressure support that reshape receptor programs and vascular–glial physiology even when laboratory [Na⁺] remains just shy of diagnostic thresholds.Within this Sodium-Switch framework, modern exposures—ultra-low-TDS/RO water and other hypotonic fluids, salt loss, renin-suppressive states (e.g., phosphate→FGF-23/α-Klotho signaling), non-electrolyte osmoles (sweeteners/polyols, gestational hyperglycemia), and barrier/oncotic leak—recurrently generate near-hyponatremic conditions. The acute response preserves perfusion but imprints receptor-level drift: AVPR1A/AVPR1B up-tuning, OXTR down-tuning, AQP4 up-regulation/redistribution, and context-dependent AVPR2/AQP2 “escape.” In the adrenal cortex, repeated RAAS surges followed by cortisol substitution bias the zona glomerulosa away from aldosterone (CYP11B2) toward a glucocorticoid-dominant phenotype (CYP11B1), weakening sodium-retentive reserve and further entraining cortisol dependence. Placental 11β-HSD2 gating modulates fetal cortisol access, making mid-gestation (~20–24 weeks) and the postnatal “walking window” key periods when vestibulo-autonomic load can consolidate a low-vagal, V1a-dominant set-point and cortical micro-hypoperfusion, with sex- and lineage-dependent amplification.Falsifiable predictions include: phase-dependent copeptin (often ↓ in dilutional/near-hyponatremic states), renin/aldosterone oscillations with episodic surges, cortisol elevation, widened osmolal gap with non-ionic osmoles, urinary AQP2/phospho-AQP2 patterns consistent with V2 escape, and tissue signatures (AVPR1A/1B↑, OXTR↓, AQP4↑; ± MR→GR tilt; ZG→ZF drift) in placenta/cord or organoids. By reframing risk as injury from the avoidance of hyponatremia rather than hyponatremia alone, this model integrates diverse environmental and clinical drivers into a single, testable physiology and motivates low-risk prevention: balanced electrolytes (remineralized fluids; sodium-aware feeding) and mitigation of renin-suppressive, osmole-heavy, or barrier-weakening exposures during the identified windows.